All episodes

Chronic Immune-Mediated Demyelinating Neuropathies - Part 1

MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients

Blood Test for Alzheimer Disease

Improving Early Recognition of Treatment-Responsive Causes of RPD

Eye Movements to Diagnose Movement Disorders - Part 5

Eye Movements to Diagnose Movement Disorders - Part 4

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Sleep Patterns and the Risk of Acute Stroke

Eye Movements to Diagnose Movement Disorders - Part 3

Eye Movements to Diagnose Movement Disorders - Part 2

Eye Movements to Diagnose Movement Disorders - Part 1

Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence

Associations Between Traumatic Brain Injury and Cognitive Decline Among Older Veteran Men

Antibody-Associated Autoimmune Encephalitis

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Diagnosis and Treatment of Trigeminal Neuralgia

Patient Travel Distance to Neurologist Visits

Prognostic Language in Critical Neurologic Illness

Depression in Multiple Sclerosis

Seizures from Sleep Are Highly Likely to Recur, New Study Shows

More Than a Wink -Identifying and Localizing Horner Syndrome

Progressive Multifocal Leukoencephalopathy

NINDS Health Equity Efforts

Sleep Disorders in Patients with Neurologic Disease - Part 3

Sleep Disorders in Patients with Neurologic Disease - Part 2

Sleep Disorders in Patients with Neurologic Disease - Part 1

Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults

Association Between Peer Victimization, Gender Diversity, Mental Health, and Recurrent Headaches in Adolescents - Part 3

Association Between Peer Victimization, Gender Diversity, Mental Health, and Recurrent Headaches in Adolescents - Part 2

Association Between Peer Victimization, Gender Diversity, Mental Health, and Recurrent Headaches in Adolescents - Part 1

Variation in Endpoints for FDA Approved Migraine Therapies

Obstructive Sleep Apnea - Part 3

Obstructive Sleep Apnea - Part 2

Obstructive Sleep Apnea - Part 1

An Updated Round Table Discussion on FND: How and Why Does FND Occur?

Low-Dose Aspirin and the Risk of Stroke

Using Brain Network Mapping in Lesion-Related Epilepsy

Spontaneous Intracranial Hypotension

Sleep Medicine Case Discussion

Lecanemab Approval

A Neurologist's Experience as a Patient with ALS

Autoimmune Encephalitis Series: Expanding the Differential

Using Handwriting and Drawing to Evaluate Movement Disorders: Part 2

Using Handwriting and Drawing to Evaluate Movement Disorders: Part 3

Using Handwriting and Drawing to Evaluate Movement Disorders: Part 1

Autoimmune Encephalitis Series: A Rationale Approach to Diagnostics and Interpretation

Autoimmune Encephalitis Series: Advancing the Science

Carotid Web

Sports, Exercise, and Seizure Control - Part 2

Sports, Exercise, and Seizure Control - Part 1

A Round Table Update Discussion on FND: Diagnosis of FND and New Phenotypes

AAN President Elect Rost to Testify on New Alzheimer's Treatments

When Myoclonus is Reversible

2024 Medicare Physician Fee Schedule Proposed Rule

Pediatric Epilepsy Surgery

Elamipretide for Mytochondrial Myopathy

Sarepta Announces FDA Approval of ELEVIDYS

Anti-Seizure Medication

Cognitive Decline Following Heart Attack

Traumatic Brain Injury in Children

New Treatment for IDH Mutant Gliomas

Patient-Assistance Programs, Kickbacks, and the Courts

Neurologic Complications of Cardiac and Pulmonary Disease: Part 3

Neurologic Complications of Cardiac and Pulmonary Disease: Part 2

Neurologic Complications of Cardiac and Pulmonary Disease: Part 1

Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke

Clinico-radiologic and Pathological Evaluation of Corticobasal Syndrome

Interstate Medical Licensure Compact

Traumatic Encephalopathy Syndrome

Migraine and Sleep

Simulation-Based Planning of ALS Trials

CSF Findings Across GBS

Substance Use and the Nervous System - Part 3

Substance Use and the Nervous System - Part 2

Substance Use and the Nervous System - Part 1

What's New in Migraine? AHS Updates

Pivotal Stroke Trials Presented at this Year's ESOC

Intracerebral Hemorrhage Trials

Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

ARCADIA Trial

Economic Cost of Functional Neurologic Disorders: A Systematic Review

Racial and Ethnic Differences in Quality of Life in Parkinson Disease

Menstrual Migraine

SOS Minute: Autoimmune Encephalitis

Scalp-Negative Epileptic Seizures: Part 4

Diagnosis and Management of Migraine in Ten Steps

Subtle Clinical Signs in Unresponsive Brain Impairment

Scalp-Negative Epileptic Seizures: Part 3

Scalp-Negative Epileptic Seizures: Part 2

Scalp-Negative Epileptic Seizures: Part 1

Effects of Daylight Saving Time Shifts on Sleep Symptoms

Biomarkers of Spontaneous Intracranial Hypotension

Sudden Unexpected Death in Epilepsy - Part 3

Sudden Unexpected Death in Epilepsy - Part 2

Sudden Unexpected Death in Epilepsy - Part 1

N-Acetyl-L-Leucine in GM2 Gangliosidoses

α-Synuclein Seed Amplification in a Large Parkinson Cohort

New-Onset Refractory Status Epilepticus (NORSE) - Part 3

New-Onset Refractory Status Epilepticus (NORSE) - Part 2

New-Onset Refractory Status Epilepticus (NORSE) - Part 1